-
of therapeutic targets and novel anticancer agents for endocrine cancers. Required Qualifications: • PhD in cancer biology, cell biology, molecular biology, bioengineering, or a closely related field
-
can be used to target them. The Sheltzer Lab leverages approaches from functional genomics, chemical biology, AI, and pharmacogenomics to uncover how cancer cells respond to small-molecule therapies
-
are available, broadly focused on understanding how genetic alterations create selective dependencies and how drugs can be used to target them. The Sheltzer Lab leverages approaches from functional genomics
-
Affairs. The FY27 minimum is $79, 056. Immunotherapies Targeting Pediatric AML Laboratory of Tanja Andrea Gruber, M.D., Ph.D. (Pediatrics, Stanford Cancer Institute) Division of Hematology Oncology Stem
-
understanding of the fundamental biological mechanisms of intestinal health and disease to discover new regenerative medicine approaches and therapeutic targets for IBD. The applicant must hold a Ph.D. or
-
-protein complexes using structural proteomics approaches (cross-linking MS, HDX-MS), AlphaFold-based structural prediction, cryo-EM (through collaborations), and targeted mutagenesis with biochemical
-
an opportunity to develop new targeted delivery technologies with a clear path toward preclinical and clinical translation. Required Qualifications: PhD in pharmaceutical sciences, chemistry, chemical engineering
-
associated with biological membranes, including large peripheral membrane complexes and integral membrane transporters. In parallel with mechanistic structural work, we develop targeted chemical probes
-
to help define a new frontier at the interface of spatial biology and therapeutics. The scholar will lead spatial-biology driven projects to identify novel spatial biomarkers, therapeutic targets, and
-
are developing approaches to target this axis including bifunctional proteins fusing antibodies to cell surface cancer proteins (e.g. PSMA, CA9) with a sialidase, which cleaves sialic acid from the cancer